Zeitschrift für Phytotherapie 2009; 30 - P11
DOI: 10.1055/s-0029-1239896

Identification and determination of phytosterols in pharmaceutical preparations

M Harkenthal 2, F Bracher 1, F Plößl 1
  • 1Department Pharmazie – Zentrum für Pharmaforschung, Ludwig-Maximilians-Universität München, Germany
  • 2GaxoSmithKline Consumer Healthcare, Bühl, Germany

For decades sterol containing plant extracts have found wide applications in the treatment of benign prostate enlargement. Especially in Germany, the extracts of Cucurbita spec. (pumpkin seeds), Sabal fructus and Urtica dioica, as well as other poorly defined „phytosterol“ preparations are widely used. In contrast to phytosterols from other plants of interest, the extracts of pumkin seeds contain significant amounts of Δ7-phytosterols and their glucosides, which are claimed to be responsible for the therapeutic effects due to their structural similarity to 5α-dihydrotestosteron.

In continuation of our research on sterol analysis we worked out a methodology for the determination of phytosterols in different pharmaceutical formulations. The method includes a sample cleanup of the unsaponifiables and the glucoside hydrolysates by a modified QuEChERS approach and the identification and determination of the sterol aglyca by GC-MS analysis of the corresponding trimethylsilyl ethers.

In a number of phytosterol preparations from local pharmacies, supermarkets and internet shops the sterol patterns were analyzed with special attention to the content of Δ5- and Δ7-phytosterols. Only in two pharmacy products (GRANU FINK PROSTA and PROSTA FINK FORTE) we found relevant amounts of Δ7-phytosterols. All other products without pumpkin seed contained no Δ7-phytosterols. Lowest content of phytosterols were found in a pumpkinseed oil product from a discounter.